Effaclar A.I.
Natural health product licensed in Canada
- Licence holder
- Laboratoires La Roche-Posay Canada
- NPN or DIN-HM
- 80002312
- Status
- Inactive licence
- Licence date
- 26 October 2006
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
cyclohexasiloxane, Isohexadecane, Stéarate de PEG-100, Isononyl isononanoate, Digluconate de Chlorhexidine, Hydroxyde de sodium, Sodium Sulfate, Gomme de xanthane, Kaolin, Capryloyl Glycine, Niacinamide, Carbomère, Alcool cétylique, Acide capryloyl salicylique, Stéarate de glycéryle, Copolymère d'acrylates, Butylcarbamate d'iodopropynyle, PEG-4 Laurate, propylèneglycol, PEG-4 Dilaurate, Silicate d'aluminium et de magnésium, Perfume, Piroctone Olamine, Eau, PEG-4, Isobutane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
Poussées de boutons. Aide à stopper l'évolution de la poussée et à favoriser la résorption des boutons. Correcteur ciblé des poussées de boutons. Pénètre les pores de la peau pour traiter les imperfections et prevenirles nouveaux boutons. Pour l'acné simple localisé au visage.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80002312
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.